Recent studies, ODYSSEY-HCM and MAPLE-HCM, explore the efficacy of cardiac myosin inhibitors in treating both obstructive and non-obstructive hypertrophic cardiomyopathy. These findings contribute to the understanding of therapeutic options for this condition.
odyssey hcm and maple hcm studies the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy obstructive and non obstructive
Original title: “The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).”